沙眼衣原体对利福平和利福布汀的敏感性和耐药性的体外研究。
In vitro studies of Chlamydia trachomatis susceptibility and resistance to rifampin and rifabutin.
作者信息
Treharne J D, Yearsley P J, Ballard R C
机构信息
Section of Virology, Institute of Ophthalmology, London, England.
出版信息
Antimicrob Agents Chemother. 1989 Aug;33(8):1393-4. doi: 10.1128/AAC.33.8.1393.
Abstract
Although rapid emergence of antibiotic-resistant mutants of Chlamydia trachomatis occurs when the organism is grown in subinhibitory concentrations of rifampin, no such mutants could be demonstrated when the organism was propagated under the same conditions in subinhibitory levels of the related drug rifabutin.
摘要
虽然沙眼衣原体在低于抑菌浓度的利福平中生长时会迅速出现抗生素抗性突变体，但当该生物体在低于抑菌水平的相关药物利福布汀的相同条件下繁殖时，却未发现此类突变体。
相似文献
1
In vitro studies of Chlamydia trachomatis susceptibility and resistance to rifampin and rifabutin.沙眼衣原体对利福平和利福布汀的敏感性和耐药性的体外研究。
Antimicrob Agents Chemother. 1989 Aug;33(8):1393-4. doi: 10.1128/AAC.33.8.1393.
2
In vitro activity of rifamycins alone and in combination with other antibiotics against Chlamydia trachomatis.利福霉素单独及与其他抗生素联合对沙眼衣原体的体外活性
Rev Infect Dis. 1983 Jul-Aug;5 Suppl 3:S556-61. doi: 10.1093/clinids/5.supplement_3.s556.
3
Emergence of resistance to rifampin and rifalazil in Chlamydophila pneumoniae and Chlamydia trachomatis.肺炎嗜衣原体和沙眼衣原体对利福平及利福拉齐耐药性的出现。
Antimicrob Agents Chemother. 2005 Mar;49(3):903-7. doi: 10.1128/AAC.49.3.903-907.2005.
4
Rifampin-resistant RNA polymerase mutants of Chlamydia trachomatis remain susceptible to the ansamycin rifalazil.沙眼衣原体耐利福平的RNA聚合酶突变体对安莎霉素利福拉齐仍然敏感。
Antimicrob Agents Chemother. 2005 Mar;49(3):1120-6. doi: 10.1128/AAC.49.3.1120-1126.2005.
5
In vitro activity of new rifamycins against rifampicin-resistant M. tuberculosis and MAIS-complex mycobacteria.新型利福霉素对耐利福平结核分枝杆菌和MAIS复合群分枝杆菌的体外活性。
Tubercle. 1987 Sep;68(3):177-82. doi: 10.1016/0041-3879(87)90053-5.
6
Comparative in vitro susceptibility studies of FCE 22250 and rifampicin on Legionella and Chlamydia trachomatis strains.FCE 22250与利福平对军团菌和沙眼衣原体菌株的体外敏感性比较研究。
Drugs Exp Clin Res. 1987;13(10):631-4.
7
8
9
Activity in vitro of rifabutin, FCE 22807, rifapentine, and rifampin against Mycobacterium microti and M. tuberculosis and their penetration into mouse peritoneal macrophages.利福布汀、FCE 22807、利福喷汀和利福平对田鼠分枝杆菌和结核分枝杆菌的体外活性及其对小鼠腹腔巨噬细胞的穿透能力。
Am Rev Respir Dis. 1992 Jan;145(1):212-4. doi: 10.1164/ajrccm/145.1.212.
10
In-vitro activity of 3-azinomethyl-rifamycin (SPA-S-565) against Chlamydia trachomatis.3-氮杂甲基利福霉素（SPA-S-565）对沙眼衣原体的体外活性
J Antimicrob Chemother. 1996 Feb;37(2):357-9. doi: 10.1093/jac/37.2.357.
引用本文的文献
1
Advances and Obstacles in the Genetic Dissection of Chlamydial Virulence.衣原体毒力遗传解析的进展与障碍。
Curr Top Microbiol Immunol. 2018;412:133-158. doi: 10.1007/82_2017_76.
2
Subinhibitory antimicrobial concentrations: A review of in vitro and in vivo data.亚抑菌抗菌浓度：体外和体内数据综述
Can J Infect Dis. 1992 Jul;3(4):193-201. doi: 10.1155/1992/793607.
3
Emergence of resistance to rifampin and rifalazil in Chlamydophila pneumoniae and Chlamydia trachomatis.肺炎嗜衣原体和沙眼衣原体对利福平及利福拉齐耐药性的出现。
Antimicrob Agents Chemother. 2005 Mar;49(3):903-7. doi: 10.1128/AAC.49.3.903-907.2005.
4
Detection of nucleotide variability in rpoB in both rifampin-sensitive and rifampin-resistant strains of Chlamydia trachomatis.在沙眼衣原体的利福平敏感株和利福平耐药株中检测rpoB基因的核苷酸变异性。
Antimicrob Agents Chemother. 2003 Jul;47(7):2316-8. doi: 10.1128/AAC.47.7.2316-2318.2003.
5
In vitro activities of rifamycin derivatives ABI-1648 (Rifalazil, KRM-1648), ABI-1657, and ABI-1131 against Chlamydia trachomatis and recent clinical isolates of Chlamydia pneumoniae.利福霉素衍生物ABI-1648（利福拉齐，KRM-1648）、ABI-1657和ABI-1131对沙眼衣原体及肺炎衣原体近期临床分离株的体外活性。
Antimicrob Agents Chemother. 2003 Mar;47(3):1135-6. doi: 10.1128/AAC.47.3.1135-1136.2003.
6
Effects of azithromycin and rifampin on Chlamydia trachomatis infection in vitro.阿奇霉素和利福平对沙眼衣原体体外感染的影响。
Antimicrob Agents Chemother. 2001 Nov;45(11):3001-8. doi: 10.1128/AAC.45.11.3001-3008.2001.
7
Effect of azithromycin plus rifampin versus that of azithromycin alone on the eradication of Chlamydia pneumoniae from lung tissue in experimental pneumonitis.阿奇霉素联合利福平与单用阿奇霉素对实验性肺炎中肺组织肺炎衣原体清除效果的比较
Antimicrob Agents Chemother. 1999 Jun;43(6):1491-3. doi: 10.1128/AAC.43.6.1491.
8
Rifabutin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy.利福布汀。对其抗菌活性、药代动力学特性及治疗效果的综述。
Drugs. 1994 Jun;47(6):983-1009. doi: 10.2165/00003495-199447060-00008.
本文引用的文献
1
In vitro susceptibility of Mycobacterium avium complex and Mycobacterium tuberculosis strains to a spiro-piperidyl rifamycin.鸟分枝杆菌复合群及结核分枝杆菌菌株对一种螺哌啶基利福霉素的体外敏感性
Am Rev Respir Dis. 1982 Sep;126(3):586-7. doi: 10.1164/arrd.1982.126.3.586.
2
Rifampicin--a new antitrachoma drug.
Nature. 1969 May 31;222(5196):851-3. doi: 10.1038/222851a0.
3
Emergence of rifampin-resistance in Chlamydia trachomatis.沙眼衣原体中利福平耐药性的出现。
Nature. 1973 Jul 20;244(5412):173-4. doi: 10.1038/244173a0.
4
Rifampicin, an antitrachoma antibiotic.利福平，一种抗沙眼抗生素。
Isr J Med Sci. 1972 Aug-Sep;8(8):1110-3.
5
Enzyme-linked immunosorbent assay for the in-vitro detection of sensitivity of Chlamydia trachomatis to antimicrobial drugs.用于体外检测沙眼衣原体对抗菌药物敏感性的酶联免疫吸附测定。
J Antimicrob Chemother. 1987 Nov;20(5):677-84. doi: 10.1093/jac/20.5.677.
6
Sensitivity of mitomycin-C treated McCoy cells for isolation of Chlamydia trachomatis from genital specimens.丝裂霉素-C处理的McCoy细胞从生殖器标本中分离沙眼衣原体的敏感性。
Eur J Clin Microbiol. 1987 Dec;6(6):653-6. doi: 10.1007/BF02013062.
7
Prediction of efficacy of antimicrobial agents in treatment of infections due to Chlamydia trachomatis.抗菌药物治疗沙眼衣原体感染疗效的预测
J Infect Dis. 1978 Nov;138(5):655-9. doi: 10.1093/infdis/138.5.655.
Zotero 插件